AMA
Adamiec-Organisciok M, Wegrzyn M, Cienciala L, Magate N, Skonieczna M, Nackiewicz J. Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(2):112-120. doi:10.5114/pg.2024.134872.
APA
Adamiec-Organisciok, M., Wegrzyn, M., Cienciala, L., Magate, N., Skonieczna, M., & Nackiewicz, J. (2024). Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(2), 112-120. https://doi.org/10.5114/pg.2024.134872
Chicago
Adamiec-Organisciok, Malgorzata, Magdalena Wegrzyn, Lukasz Cienciala, Ngoni Magate, Magdalena Skonieczna, and Joanna Nackiewicz. 2024. "Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines". Gastroenterology Review/Przegląd Gastroenterologiczny 19 (2): 112-120. doi:10.5114/pg.2024.134872.
Harvard
Adamiec-Organisciok, M., Wegrzyn, M., Cienciala, L., Magate, N., Skonieczna, M., and Nackiewicz, J. (2024). Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(2), pp.112-120. https://doi.org/10.5114/pg.2024.134872
MLA
Adamiec-Organisciok, Malgorzata et al. "Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 19, no. 2, 2024, pp. 112-120. doi:10.5114/pg.2024.134872.
Vancouver
Adamiec-Organisciok M, Wegrzyn M, Cienciala L, Magate N, Skonieczna M, Nackiewicz J. Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(2):112-120. doi:10.5114/pg.2024.134872.
